Known for its implantable ventricular assist device, Heartware International Inc. (Framingham, Mass.) (NASDAQ: HTWR) defended its pending acquisition of Valtech Cardio Ltd. (Yehuda, Israel) in response to a notice from Engaged Capital LLC nominating three directors for Heartware's board. The threat comes six months ahead of the company's annual meeting, usually held in June. Read More
